Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capilano Honey is a prominent Australian honey producer that has significantly expanded its footprint into the life sciences and healthcare sectors through its focus on therapeutic honey. The company specializes in the production and clinical validation of medical-grade Manuka honey, which is utilized for its potent antibacterial and wound-healing properties. Operating under the parent entity Hive + Wellness Australia, Capilano invests in research to explore the bioactive components of honey, such as methylglyoxal, for applications in dermatology and digestive health. Their product range includes TGA-listed (Therapeutic Goods Administration) honey products designed for topical application and general wellness. The company maintains a robust supply chain and manufacturing infrastructure to ensure the purity and potency required for healthcare applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Capilano Honey.